A detailed history of Glenview Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Glenview Trust CO holds 9,429 shares of AMGN stock, worth $3.04 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
9,429
Previous 9,597 1.75%
Holding current value
$3.04 Million
Previous $2.73 Million 7.99%
% of portfolio
0.06%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $44,142 - $53,644
-168 Reduced 1.75%
9,429 $2.95 Million
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $28,231 - $34,078
105 Added 1.11%
9,597 $2.73 Million
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $82,591 - $93,172
323 Added 3.52%
9,492 $2.73 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $17,054 - $21,173
-78 Reduced 0.84%
9,169 $2.46 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $31,283 - $36,992
146 Added 1.6%
9,247 $2.05 Million
Q1 2023

May 09, 2023

BUY
$225.79 - $275.2 $24,836 - $30,272
110 Added 1.22%
9,101 $2.2 Million
Q4 2022

Feb 08, 2023

SELL
$229.03 - $291.01 $52,218 - $66,350
-228 Reduced 2.47%
8,991 $2.36 Million
Q3 2022

Nov 04, 2022

BUY
$224.46 - $253.15 $13,018 - $14,682
58 Added 0.63%
9,219 $2.08 Million
Q2 2022

Aug 10, 2022

BUY
$230.71 - $256.74 $155,498 - $173,042
674 Added 7.94%
9,161 $2.23 Million
Q1 2022

May 11, 2022

BUY
$219.27 - $242.57 $219,050 - $242,327
999 Added 13.34%
8,487 $2.05 Million
Q4 2021

Feb 10, 2022

SELL
$198.88 - $227.6 $54,692 - $62,590
-275 Reduced 3.54%
7,488 $1.68 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $67,714 - $79,335
-319 Reduced 3.95%
7,763 $1.65 Million
Q2 2021

Aug 11, 2021

BUY
$233.58 - $259.14 $14,014 - $15,548
60 Added 0.75%
8,082 $1.97 Million
Q1 2021

May 12, 2021

BUY
$221.91 - $258.6 $232,339 - $270,754
1,047 Added 15.01%
8,022 $2 Million
Q4 2020

Feb 02, 2021

SELL
$216.38 - $257.67 $10,819 - $12,883
-50 Reduced 0.71%
6,975 $1.6 Million
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $2,111 - $2,348
-9 Reduced 0.13%
7,025 $1.79 Million
Q2 2020

Aug 12, 2020

SELL
$197.81 - $242.74 $35,605 - $43,693
-180 Reduced 2.5%
7,034 $1.66 Million
Q1 2020

Apr 28, 2020

BUY
$182.24 - $241.7 $117,362 - $155,654
644 Added 9.8%
7,214 $1.46 Million
Q4 2019

Feb 06, 2020

BUY
$189.21 - $243.2 $127,905 - $164,403
676 Added 11.47%
6,570 $1.58 Million
Q3 2019

Nov 14, 2019

BUY
$174.11 - $208.62 $97,501 - $116,827
560 Added 10.5%
5,894 $1.14 Million
Q2 2019

Aug 08, 2019

SELL
$166.7 - $195.41 $247,216 - $289,793
-1,483 Reduced 21.75%
5,334 $0
Q1 2019

May 14, 2019

BUY
$180.87 - $203.88 $27,853 - $31,397
154 Added 2.31%
6,817 $1.3 Million
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $89,200 - $104,125
500 Added 8.11%
6,663 $1.3 Million
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $1.14 Million - $1.29 Million
6,163 New
6,163 $1.28 Million
Q2 2018

Aug 10, 2018

SELL
$166.05 - $186.51 $1.04 Million - $1.17 Million
-6,255 Closed
0 $0
Q1 2018

May 14, 2018

SELL
$169.43 - $198.0 $3,558 - $4,158
-21 Reduced 0.33%
6,255 $0
Q4 2017

Feb 06, 2018

BUY
$168.79 - $188.59 $11,984 - $13,389
71 Added 1.14%
6,276 $1.09 Million
Q3 2017

Nov 07, 2017

BUY
$167.29 - $191.0 $1.04 Million - $1.19 Million
6,205
6,205 $1.16 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Glenview Trust CO Portfolio

Follow Glenview Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Trust CO with notifications on news.